TW200736207A - Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin D3 compounds - Google Patents
Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin D3 compoundsInfo
- Publication number
- TW200736207A TW200736207A TW095110651A TW95110651A TW200736207A TW 200736207 A TW200736207 A TW 200736207A TW 095110651 A TW095110651 A TW 095110651A TW 95110651 A TW95110651 A TW 95110651A TW 200736207 A TW200736207 A TW 200736207A
- Authority
- TW
- Taiwan
- Prior art keywords
- methyl
- compounds
- methods
- secondary hyperparathyroidism
- treating osteoporosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66439705P | 2005-03-23 | 2005-03-23 | |
PCT/IB2006/001541 WO2006117684A1 (en) | 2005-03-23 | 2006-03-23 | Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200736207A true TW200736207A (en) | 2007-10-01 |
Family
ID=36793191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095110651A TW200736207A (en) | 2005-03-23 | 2006-03-28 | Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin D3 compounds |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090298799A1 (zh) |
EP (1) | EP1898924A1 (zh) |
CN (1) | CN101198336A (zh) |
CA (1) | CA2602464A1 (zh) |
TW (1) | TW200736207A (zh) |
WO (1) | WO2006117684A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1879596A4 (en) * | 2005-03-23 | 2009-01-21 | Bioxell Spa | 20 ALKYL, GEMINI VITAMIN D3 COMPOUNDS AND METHOD OF USE THEREOF |
US9616109B2 (en) | 2014-10-22 | 2017-04-11 | Extend Biosciences, Inc. | Insulin vitamin D conjugates |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030962A (en) * | 1997-04-28 | 2000-02-29 | Synttex (U.S.A.) Inc. | Vitamin D3 analogs with bis C-20 side chains |
AU762481C (en) * | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6516294B1 (en) * | 1999-07-01 | 2003-02-04 | The Regents Of The University Of California | Nuclear receptor for 1α,25-dihydroxyvitamin D3 useful for selection of vitamin D3 ligands and a method therefor |
JP2006525367A (ja) * | 2003-04-30 | 2006-11-09 | ビオクセル エッセ ピ ア | ジェミニビタミンd3化合物及びその使用方法 |
-
2006
- 2006-03-23 WO PCT/IB2006/001541 patent/WO2006117684A1/en active Application Filing
- 2006-03-23 CA CA002602464A patent/CA2602464A1/en not_active Abandoned
- 2006-03-23 US US11/886,922 patent/US20090298799A1/en not_active Abandoned
- 2006-03-23 EP EP06765498A patent/EP1898924A1/en not_active Withdrawn
- 2006-03-23 CN CNA2006800179068A patent/CN101198336A/zh active Pending
- 2006-03-28 TW TW095110651A patent/TW200736207A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2602464A1 (en) | 2006-11-09 |
US20090298799A1 (en) | 2009-12-03 |
CN101198336A (zh) | 2008-06-11 |
WO2006117684A1 (en) | 2006-11-09 |
EP1898924A1 (en) | 2008-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I1 (zh) | ||
MX2009009292A (es) | Compuestos activos en ppar. | |
TW200716624A (en) | Compounds for modulating TRPV3 function | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
WO2012034116A3 (en) | Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders | |
WO2011022489A3 (en) | (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders | |
TW200607513A (en) | Certain chemical entities, compositions, and methods | |
MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
MX2009011211A (es) | Indoles sustituidos en la posicion 7 inhibidores de mci-1. | |
MXPA05012680A (es) | Indoles novedosos de 3-azufre sustituidos. | |
TW200510303A (en) | Novel compounds | |
TN2010000140A1 (en) | Compositions and methods for use antibodies against sclerostin | |
SG170813A1 (en) | New compounds | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
WO2009052431A3 (en) | Cd19 binding agents and uses thereof | |
TW200732296A (en) | Novel compounds | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
UA99936C2 (en) | Biaryl substituted azabicyclic alkane derivatives | |
MX2007016469A (es) | Metodos de tratamiento utilizando ansamicinas de hidroquinona. | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
GB2466912A (en) | Compositions and methods for treating lysosomal disorders | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
WO2007056469A3 (en) | Certain chemical entities, compositions, and methods | |
WO2007056143A3 (en) | Certain chemical entities, compositions, and methods | |
ZA200802848B (en) | Potassium channel inhibitors |